141 related articles for article (PubMed ID: 26559489)
1. Generation of enterocyte-like cells from human induced pluripotent stem cells for drug absorption and metabolism studies in human small intestine.
Ozawa T; Takayama K; Okamoto R; Negoro R; Sakurai F; Tachibana M; Kawabata K; Mizuguchi H
Sci Rep; 2015 Nov; 5():16479. PubMed ID: 26559489
[TBL] [Abstract][Full Text] [Related]
2. Modeling of drug-mediated CYP3A4 induction by using human iPS cell-derived enterocyte-like cells.
Negoro R; Takayama K; Nagamoto Y; Sakurai F; Tachibana M; Mizuguchi H
Biochem Biophys Res Commun; 2016 Apr; 472(4):631-6. PubMed ID: 26966071
[TBL] [Abstract][Full Text] [Related]
3. Functional intestinal monolayers from organoids derived from human iPS cells for drug discovery research.
Inui T; Uraya Y; Yokota J; Yamashita T; Kawai K; Okada K; Ueyama-Toba Y; Mizuguchi H
Stem Cell Res Ther; 2024 Feb; 15(1):57. PubMed ID: 38424603
[TBL] [Abstract][Full Text] [Related]
4. Characteristic Analysis of Intestinal Transport in Enterocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells.
Kodama N; Iwao T; Katano T; Ohta K; Yuasa H; Matsunaga T
Drug Metab Dispos; 2016 Oct; 44(10):0. PubMed ID: 27417181
[TBL] [Abstract][Full Text] [Related]
5. Generation of enterocyte-like cells with pharmacokinetic functions from human induced pluripotent stem cells using small-molecule compounds.
Iwao T; Kodama N; Kondo Y; Kabeya T; Nakamura K; Horikawa T; Niwa T; Kurose K; Matsunaga T
Drug Metab Dispos; 2015 Apr; 43(4):603-10. PubMed ID: 25650381
[TBL] [Abstract][Full Text] [Related]
6. Generation of Human-Induced Pluripotent Stem Cell-Derived Functional Enterocyte-Like Cells for Pharmacokinetic Studies.
Yoshida S; Honjo T; Iino K; Ishibe R; Leo S; Shimada T; Watanabe T; Ishikawa M; Maeda K; Kusuhara H; Shiraki N; Kume S
Stem Cell Reports; 2021 Feb; 16(2):295-308. PubMed ID: 33513361
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of mitogen-activated protein kinase kinase, DNA methyltransferase, and transforming growth factor-β promotes differentiation of human induced pluripotent stem cells into enterocytes.
Kodama N; Iwao T; Kabeya T; Horikawa T; Niwa T; Kondo Y; Nakamura K; Matsunaga T
Drug Metab Pharmacokinet; 2016 Jun; 31(3):193-200. PubMed ID: 27161454
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of carboxylesterase in human induced pluripotent stem cell-derived enterocytes.
Kabeya T; Matsumura W; Iwao T; Hosokawa M; Matsunaga T
Biochem Biophys Res Commun; 2017 Apr; 486(1):143-148. PubMed ID: 28285137
[TBL] [Abstract][Full Text] [Related]
9. Generation of Human iPSC-Derived Intestinal Epithelial Cell Monolayers by CDX2 Transduction.
Takayama K; Negoro R; Yamashita T; Kawai K; Ichikawa M; Mori T; Nakatsu N; Harada K; Ito S; Yamada H; Yamaura Y; Hirata K; Ishida S; Mizuguchi H
Cell Mol Gastroenterol Hepatol; 2019; 8(3):513-526. PubMed ID: 31228606
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Vitamin D3 and Valproic Acid on the Maturation of Human-Induced Pluripotent Stem Cell-Derived Enterocyte-Like Cells.
Leo S; Kato Y; Wu Y; Yokota M; Koike M; Yui S; Tsuchiya K; Shiraki N; Kume S
Stem Cells; 2023 Aug; 41(8):775-791. PubMed ID: 37228023
[TBL] [Abstract][Full Text] [Related]
11. Efficient Generation of Small Intestinal Epithelial-like Cells from Human iPSCs for Drug Absorption and Metabolism Studies.
Negoro R; Takayama K; Kawai K; Harada K; Sakurai F; Hirata K; Mizuguchi H
Stem Cell Reports; 2018 Dec; 11(6):1539-1550. PubMed ID: 30472010
[TBL] [Abstract][Full Text] [Related]
12. Establishment and Characterization of Novel Human Intestinal In Vitro Models for Absorption and First-Pass Metabolism Studies.
Przybylla R; Mullins CS; Krohn M; Oswald S; Linnebacher M
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077251
[TBL] [Abstract][Full Text] [Related]
13. Gellan Gum Promotes the Differentiation of Enterocytes from Human Induced Pluripotent Stem Cells.
Qiu S; Kabeya T; Ogawa I; Anno S; Hayashi H; Kanaki T; Hashita T; Iwao T; Matsunaga T
Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33050367
[TBL] [Abstract][Full Text] [Related]
14. [Utilization of Human iPS Cells for Evaluation of Drug Disposition and Mucosal Damages in the Small Intestine].
Iwao T
Yakugaku Zasshi; 2023; 143(3):243-247. PubMed ID: 36858557
[TBL] [Abstract][Full Text] [Related]
15. iPSC-Derived Enterocyte-like Cells for Drug Absorption and Metabolism Studies.
Macedo MH; Araújo F; Martínez E; Barrias C; Sarmento B
Trends Mol Med; 2018 Aug; 24(8):696-708. PubMed ID: 29945758
[TBL] [Abstract][Full Text] [Related]
16. Human small intestinal epithelial cells differentiated from adult intestinal stem cells as a novel system for predicting oral drug absorption in humans.
Takenaka T; Harada N; Kuze J; Chiba M; Iwao T; Matsunaga T
Drug Metab Dispos; 2014 Nov; 42(11):1947-54. PubMed ID: 25200868
[TBL] [Abstract][Full Text] [Related]
17. Air-liquid interface culture and modified culture medium promote the differentiation of human induced pluripotent stem cells into intestinal epithelial cells.
Shirai K; Qiu S; Minowa H; Hashita T; Iwao T; Matsunaga T
Drug Metab Pharmacokinet; 2024 Apr; 55():100994. PubMed ID: 38452616
[TBL] [Abstract][Full Text] [Related]
18.
Deguchi S; Shintani T; Harada K; Okamoto T; Takemura A; Hirata K; Ito K; Takayama K; Mizuguchi H
Hepatol Commun; 2021 Aug; 5(8):1385-1399. PubMed ID: 34430783
[TBL] [Abstract][Full Text] [Related]
19. A three-dimensional coculture of enterocytes, monocytes and dendritic cells to model inflamed intestinal mucosa in vitro.
Leonard F; Collnot EM; Lehr CM
Mol Pharm; 2010 Dec; 7(6):2103-19. PubMed ID: 20809575
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic functions of human induced pluripotent stem cell-derived small intestinal epithelial cells.
Kabeya T; Mima S; Imakura Y; Miyashita T; Ogura I; Yamada T; Yasujima T; Yuasa H; Iwao T; Matsunaga T
Drug Metab Pharmacokinet; 2020 Aug; 35(4):374-382. PubMed ID: 32651148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
